Skip Navigation
Skip to contents

JMD : Journal of Movement Disorders

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
2 "Jeong-Wook Park"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
Cardiovascular Autonomic Dysfunction in Mild and Advanced Parkinson’s Disease
Joong-Seok Kim, Si-Hoon Lee, Yoon-Sang Oh, Jeong-Wook Park, Jae-Young An, Sung-Kyung Park, Si-Ryung Han, Kwang-Soo Lee
J Mov Disord. 2016;9(2):97-103.   Published online March 28, 2016
DOI: https://doi.org/10.14802/jmd.16001
  • 17,311 View
  • 194 Download
  • 25 Citations
AbstractAbstract PDF
Objective
The purpose of the present study was to investigate cardiovascular autonomic dysfunction in patients with Parkinson’s disease (PD) with mild to severe stages of motor symptoms and to compare cardiovascular autonomic dysfunction between drug-naïve and dopaminergic drug-treated groups.
Methods
This study included 188 PD patients and 25 age-matched healthy controls who underwent head-up tilt-testing, 24-h ambulatory blood pressure (BP) monitoring and 24-h Holter monitoring. Autonomic function test results were evaluated among groups categorized by motor symptom severities (mild vs. moderate vs. severe) and treatment (drug-naïve or dopaminergic drug treatment).
Results
Orthostatic hypotension and supine hypertension were more frequent in patients with PD than in healthy controls. The frequencies of orthostatic hypotension, supine hypertension, nocturnal hypertension and non-dipping were not different among groups. Additionally, no significant differences were detected in supine BP, orthostatic BP change, nighttime BP, nocturnal BP dipping, or heart rate variabilities among groups.
Conclusions
Cardiovascular autonomic dysfunction is not confined to moderate to severe PD patients, and starts early in the course of the disease in a high proportion of PD patients. In addition, dopaminergic drug treatments do not affect cardiovascular autonomic function.

Citations

Citations to this article as recorded by  
  • Central Aortic Pressure and Arterial Stiffness in Parkinson’s Disease: A Comparative Study
    Mehmet Balal, Meltem Demirkiran, Saime Paydas, Seyed-Mohammad Fereshtehnejad
    Parkinson's Disease.2022; 2022: 1.     CrossRef
  • Blood Pressure Patterns in Patients with Parkinson’s Disease: A Systematic Review
    Delia Tulbă, Liviu Cozma, Paul Bălănescu, Adrian Buzea, Cristian Băicuș, Bogdan Ovidiu Popescu
    Journal of Personalized Medicine.2021; 11(2): 129.     CrossRef
  • Inverted circadian variation of arterial pressure in a geriatric patient: an indicator of autonomic dysfunction
    Siddhartha Lieten, Aziz Debain, Bert Bravenboer, Tony Mets
    BMC Geriatrics.2021;[Epub]     CrossRef
  • Autonomic dysfunction and heart rate variability with Holter monitoring: a diagnostic look at autonomic regulation
    Beatrice De Maria, Laura Adelaide Dalla Vecchia, Alberto Porta, Maria Teresa La Rovere
    Herzschrittmachertherapie + Elektrophysiologie.2021; 32(3): 315.     CrossRef
  • Heart Rate Variability Analyses in Parkinson’s Disease: A Systematic Review and Meta-Analysis
    Konstantin G. Heimrich, Thomas Lehmann, Peter Schlattmann, Tino Prell
    Brain Sciences.2021; 11(8): 959.     CrossRef
  • Association of orthostatic hypotension with Parkinson’s disease: a meta-analysis
    Feifei Mu, Qian Jiao, Xixun Du, Hong Jiang
    Neurological Sciences.2020; 41(6): 1419.     CrossRef
  • Dizziness in patients with early stages of Parkinson's disease: Prevalence, clinical characteristics and implications
    Kyum‐Yil Kwon, Suyeon Park, Mina Lee, Hyunjin Ju, Kayeong Im, Byung‐Euk Joo, Kyung Bok Lee, Hakjae Roh, Moo‐Young Ahn
    Geriatrics & Gerontology International.2020; 20(5): 443.     CrossRef
  • The Dysfunctional Autonomic Function and “Dysfunctional” Fatigue in Drug Naïve Parkinson’s Disease
    Jong Hyeon Ahn, Minkyeong Kim, Jun Kyu Mun, Yoonsu Cho, Ji Sun Kim, Jinyoung Youn, Joong-Seok Kim, Jin Whan Cho
    Journal of Parkinson's Disease.2020; 10(2): 605.     CrossRef
  • Clinical Perspectives of Parkinson's Disease for Ophthalmologists, Otorhinolaryngologists, Cardiologists, Dentists, Gastroenterologists, Urologists, Physiatrists, and Psychiatrists
    Ji-Hyun Choi, Jong-Min Kim, Hee Kyung Yang, Hyo-Jung Lee, Cheol Min Shin, Seong Jin Jeong, Won-Seok Kim, Ji Won Han, In-Young Yoon, Yoo Sung Song, Yun Jung Bae
    Journal of Korean Medical Science.2020;[Epub]     CrossRef
  • Autonomic Dysfunction in Parkinson’s Disease
    Ronald F. Pfeiffer
    Neurotherapeutics.2020; 17(4): 1464.     CrossRef
  • Dysautonomia Is Linked to Striatal Dopamine Deficits and Regional Cerebral Perfusion in Early Parkinson Disease
    Hae-Won Shin, Seok Jong Chung, Sangwon Lee, Jungho Cha, Young H. Sohn, Mijin Yun, Phil Hyu Lee
    Clinical Nuclear Medicine.2020; 45(8): e342.     CrossRef
  • Characteristics of the 24-h ambulatory blood pressure monitoring in patients with Parkinson's disease – the SFC BP multicentre study in China
    Shi-Wu Chen, Yu-Kai Wang, Rong-Hua Dou, Xin-Yi Xie, Yong-Bo Hu, Nan Ding, Guo-Hua Zhang, Hai-Fang Jing, Wei-Dong Zhao, Yan Xue, Yan Li, Gang Wang
    Journal of Hypertension.2020; 38(11): 2270.     CrossRef
  • Parkinson’s disease with orthostatic hypotension: analyses of clinical characteristics and influencing factors
    Lixia Li, Peng Guo, Duyu Ding, Tenghong Lian, Lijun Zuo, Fenghe Du, Wei Zhang
    Neurological Research.2019; 41(8): 734.     CrossRef
  • Neurogenic Orthostatic Hypotension in Parkinson Disease: A Primer
    Jeremy K. Cutsforth-Gregory, Phillip A. Low
    Neurology and Therapy.2019; 8(2): 307.     CrossRef
  • Increased markers of cardiac vagal activity in leucine-rich repeat kinase 2-associated Parkinson’s disease
    Claudia Carricarte Naranjo, Connie Marras, Naomi P. Visanji, David J. Cornforth, Lazaro Sanchez-Rodriguez, Birgitt Schüle, Samuel M. Goldman, Mario Estévez, Phyllis K. Stein, Anthony E. Lang, Herbert F. Jelinek, Andrés Machado
    Clinical Autonomic Research.2019; 29(6): 603.     CrossRef
  • Considerations before initiating therapy in Parkinsonism: basing on the quality of life
    Shu-Jin He, Zhen-Yang Liu, Yu-Jie Yang, Cong Shen, Yu-Jie Du, Xin-Yue Zhou, Jue Zhao, Yi-Min Sun, Ke Yang, Jian-Jun Wu, Feng-Tao Liu, Jian Wang
    Journal of Neurology.2019; 266(12): 3119.     CrossRef
  • Increased risk of all‐cause mortality associated with domperidone use in Parkinson's patients: a population‐based cohort study in the UK
    Marina Simeonova, Frank Vries, Sander Pouwels, Johanna H. M. Driessen, Hubert G.M. Leufkens, Suzanne M. Cadarette, Andrea M. Burden
    British Journal of Clinical Pharmacology.2018; 84(11): 2551.     CrossRef
  • Validation of the Korean Version of the Scale for Outcomes in Parkinson’s Disease-Autonomic
    Ji-Young Kim, In-Uk Song, Seong-Beom Koh, Tae-Beom Ahn, Sang Jin Kim, Sang-Myung Cheon, Jin Whan Cho, Yun Joong Kim, Hyeo-Il Ma, Mee-Young Park, Jong Sam Baik, Phil Hyu Lee, Sun Ju Chung, Jong-Min Kim, Han-Joon Kim, Young-Hee Sung, Do Young Kwon, Jae-Hyeo
    Journal of Movement Disorders.2017; 10(1): 29.     CrossRef
  • Cardiovascular Autonomic Dysfunction in Patients with Drug-Induced Parkinsonism
    Joong-Seok Kim, Dong-Woo Ryu, Ju-Hee Oh, Yang-Hyun Lee, Sung-Jin Park, Kipyung Jeon, Jong-Yun Lee, Seong Hee Ho, Jungmin So, Jin Hee Im, Kwang-Soo Lee
    Journal of Clinical Neurology.2017; 13(1): 15.     CrossRef
  • Normal ‘heart’ in Parkinson's disease: is this a distinct clinical phenotype?
    J.-S. Kim, H.-E. Park, I.-S. Park, Y.-S. Oh, D.-W. Ryu, I.-U. Song, Y.-A. Jung, I. R. Yoo, H.-S. Choi, P. H. Lee, K.-S. Lee
    European Journal of Neurology.2017; 24(2): 349.     CrossRef
  • The composite autonomic symptom scale 31 is a useful screening tool for patients with Parkinsonism
    Younsoo Kim, Jin Myoung Seok, Jongkyu Park, Kun-Hyun Kim, Ju-Hong Min, Jin Whan Cho, Suyeon Park, Hyun-jin Kim, Byoung Joon Kim, Jinyoung Youn, Pedro Gonzalez-Alegre
    PLOS ONE.2017; 12(7): e0180744.     CrossRef
  • Cardiac sympathetic denervation predicts PD in at-risk individuals
    David S. Goldstein, Courtney Holmes, Grisel J. Lopez, Tianxia Wu, Yehonatan Sharabi
    Parkinsonism & Related Disorders.2017;[Epub]     CrossRef
  • Loss of cutaneous large and small fibers in naive and l-dopa–treated PD patients
    Maria Nolano, Vincenzo Provitera, Fiore Manganelli, Rosa Iodice, Annamaria Stancanelli, Giuseppe Caporaso, Annamaria Saltalamacchia, Francesca Califano, Bernardo Lanzillo, Marina Picillo, Paolo Barone, Lucio Santoro
    Neurology.2017; 89(8): 776.     CrossRef
  • Arterial Stiffness and Cardiovascular Autonomic Dysfunction in Patients with Parkinson's Disease
    Joong-Seok Kim, Si-Hoon Lee, Yoon-Sang Oh, Jeong-Wook Park, Jae-Young An, Hyun-Seok Choi, Kwang-Soo Lee
    Neurodegenerative Diseases.2017; 17(2-3): 89.     CrossRef
  • Prevalence and Prescribed Treatments of Orthostatic Hypotension in Institutionalized Patients with Parkinson’s Disease
    ALAJ Hommel, MJ Faber, NJ Weerkamp, JG van Dijk, BR Bloem, RT Koopmans
    Journal of Parkinson's Disease.2016; 6(4): 805.     CrossRef
The Frequency and Severity of Gastrointestinal Symptoms in Patients with Early Parkinson’s Disease
Hye-Young Sung, Jeong-Wook Park, Joong-Seok Kim
J Mov Disord. 2014;7(1):7-12.   Published online April 30, 2014
DOI: https://doi.org/10.14802/jmd.14002
  • 16,103 View
  • 160 Download
  • 42 Citations
AbstractAbstract PDF
Objective: Although gastrointestinal dysfunctions occur in the majority of patients with Parkinson’s disease (PD), they are often unrecognized because many patients remain relatively asymptomatic in the early stage. We investigated the frequency of gastrointestinal symptoms in patients with PD using newly developed gastrointestinal symptom questionnaires.
Methods: Early PD patients with a symptom duration not exceeding 3 years were included in this study. All PD patients were evaluated using a questionnaire, which consisted of three relevant domains: oropharyngoesophageal (10 items); gastric (3 items); and intestinal-anorectal (7 items). The frequency of symptoms was calculated as a proportion with an item score ≥ 2.
Results: Of the 54 patients enrolled, 48 patients (88.9%) responded that bowel symptoms developed before the onset of Parkinsonian motor symptoms, and four patients reported that the onset of two types of symptoms (i.e., bowel and neurological) occurred approximately simultaneously, with only months between them. The frequencies of gastrointestinal symptoms are as follows: speech disturbance (40.7%), drooling (24.1%), sense of getting stuck (31.5%), choking (27.8%), globus pharyngis (16.7%), repetitive deglutition (29.6%), pain during swallowing (5.6%), food regurgitation (3.7%), acid reflux (7.4%), nausea/ vomiting (11.1%), early satiety (16.7%), postprandial fullness (14.8%), epigastric soreness (9.3%), abdominal pain (3.7%), constipation (46.3%), excessive strain during defecation (33.3%), fecal incontinence (7.4%), tenesmus (20.4%), loose stool or diarrhea (3.7%), and difficulty in relaxing anal sphincter (11.1%). Two patients were scored at zero.
Conclusions: Our findings confirm that gastrointestinal dysfunction occurs in early PD in relatively high frequency.

Citations

Citations to this article as recorded by  
  • Related Effects of Methamphetamine on the Intestinal Barrier via Cytokines, and Potential Mechanisms by Which Methamphetamine May Occur on the Brain-Gut Axis
    Yuansen Li, Deshenyue Kong, Ke Bi, Huayou Luo
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • Alpha-synuclein and tau are abundantly expressed in the ENS of the human appendix and monkey cecum
    Alexandra D. Zinnen, Jonathan Vichich, Jeanette M. Metzger, Julia C. Gambardella, Viktoriya Bondarenko, Heather A. Simmons, Marina E. Emborg, Stephan N. Witt
    PLOS ONE.2022; 17(6): e0269190.     CrossRef
  • Management of dysphagia and gastroparesis in Parkinson’s disease in real-world clinical practice – Balancing pharmacological and non-pharmacological approaches
    Roongroj Bhidayasiri, Warongporn Phuenpathom, Ai Huey Tan, Valentina Leta, Saisamorn Phumphid, K. Ray Chaudhuri, Pramod Kumar Pal
    Frontiers in Aging Neuroscience.2022;[Epub]     CrossRef
  • Mechanisms of development of constipation in Parkinson’s disease and therapeutic approaches
    E.A. Katunina, N.N. Shipilova, D.A. Katunin
    Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova.2022; 122(8): 21.     CrossRef
  • Intestinal Permeability, Dysbiosis, Inflammation and Enteric Glia Cells: The Intestinal Etiology of Parkinson’s Disease
    Huijia Yang, Song Li, Weidong Le
    Aging and disease.2022; 13(5): 1381.     CrossRef
  • The interplay between the gut-brain axis and the microbiome: A perspective on psychiatric and neurodegenerative disorders
    Yasir Bashir, Asad U. Khan
    Frontiers in Neuroscience.2022;[Epub]     CrossRef
  • Clinical features and relative factors of constipation in a cohort of Chinese patients with Parkinson's disease
    Bai-Hua Sun, Tao Wang, Nian-Ying Li, Qiong Wu, Jin Qiao
    World Journal of Gastrointestinal Pharmacology and Therapeutics.2021; 12(1): 21.     CrossRef
  • Characterization of Gastrointestinal Symptom Type and Severity in Parkinson's Disease: A Case–Control Study in an Australian Cohort
    Jade E. Kenna, Megan C. Bakeberg, Anastazja M. Gorecki, Alfred Chin Yen Tay, Samantha Winter, Frank L. Mastaglia, Ryan S. Anderton
    Movement Disorders Clinical Practice.2021; 8(2): 245.     CrossRef
  • Granisetron, a selective 5-HT3 antagonist, reduces L-3,4-dihydroxyphenylalanine-induced abnormal involuntary movements in the 6-hydroxydopamine-lesioned rat
    Cynthia Kwan, Imane Frouni, Dominique Bédard, Adjia Hamadjida, Philippe Huot
    Behavioural Pharmacology.2021; 32(1): 43.     CrossRef
  • Deglutition Impairment during Dual Task in Parkinson Disease Is Associated with Cognitive Status
    Luciana Grolli Ardenghi, Alana Verza Signorini, Gerson Schulz Maahs, Fabio Selaimen, Konrado Massing Deutsch, Silvia Dornelles, Carlos Roberto de Mello Rieder
    International Archives of Otorhinolaryngology.2021; 25(01): e41.     CrossRef
  • Spectrum of Non-Motor Symptoms in Parkinson's Disease
    Maithrayie Kumaresan, Safeera Khan
    Cureus.2021;[Epub]     CrossRef
  • Onset of Skin, Gut, and Genitourinary Prodromal Parkinson's Disease: A Study of 1.5 Million Veterans
    Gregory D. Scott, Miranda M. Lim, Matthew G. Drake, Randy Woltjer, Joseph F. Quinn
    Movement Disorders.2021; 36(9): 2094.     CrossRef
  • The Gastrointestinal Dysfunction Scale for Parkinson's Disease
    Marta Camacho, Julia C. Greenland, Caroline H. Williams‐Gray
    Movement Disorders.2021; 36(10): 2358.     CrossRef
  • The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders
    Katarzyna Socała, Urszula Doboszewska, Aleksandra Szopa, Anna Serefko, Marcin Włodarczyk, Anna Zielińska, Ewa Poleszak, Jakub Fichna, Piotr Wlaź
    Pharmacological Research.2021; 172: 105840.     CrossRef
  • Neuro-Immunity and Gut Dysbiosis Drive Parkinson’s Disease-Induced Pain
    Katiane Roversi, Natalia Callai-Silva, Karine Roversi, May Griffith, Christos Boutopoulos, Rui Daniel Prediger, Sébastien Talbot
    Frontiers in Immunology.2021;[Epub]     CrossRef
  • Autonomic dysfunction in Parkinson’s disease: Implications for pathophysiology, diagnosis, and treatment
    Zhichun Chen, Guanglu Li, Jun Liu
    Neurobiology of Disease.2020; 134: 104700.     CrossRef
  • Double‐Blind , Randomized, Placebo‐Controlled Trial of DA ‐9701 in Parkinson's Disease: PASS ‐ GI Study
    Ji‐Hyun Choi, Jee‐Young Lee, Jin Whan Cho, Seong‐Beom Koh, Young Soon Yang, Dalla Yoo, Cheol‐Min Shin, Hee Tae Kim
    Movement Disorders.2020; 35(11): 1966.     CrossRef
  • Parkinson disease and the gut: new insights into pathogenesis and clinical relevance
    R. Alberto Travagli, Kirsteen N. Browning, Michael Camilleri
    Nature Reviews Gastroenterology & Hepatology.2020; 17(11): 673.     CrossRef
  • Expanding the brain researcher's toolkit
    Viviana Gradinaru
    Science.2020; 369(6504): 637.     CrossRef
  • Excessive buccal saliva in patients with Parkinson’s disease of the French COPARK cohort
    Olivier Rascol, Laurence Negre-Pages, Philippe Damier, Arnaud Delval, Pascal Derkinderen, Alain Destée, Margherita Fabbri, Wassilios G. Meissner, Amine Rachdi, François Tison, Santiago Perez-Lloret
    Journal of Neural Transmission.2020; 127(12): 1607.     CrossRef
  • Struktur und Efferenzen der Substantia nigra pars compacta beim idiopathischen Parkinson-Syndrom
    Peter Urban, Bjorn Falkenburger, Wolfgang H. Jost, Gerhard Ransmayr, Peter Riederer, Christian Winkler
    Fortschritte der Neurologie · Psychiatrie.2020; 88(09): 591.     CrossRef
  • Parkinson’s disease: Are gut microbes involved?
    Yogesh Bhattarai, Purna C. Kashyap
    American Journal of Physiology-Gastrointestinal and Liver Physiology.2020; 319(5): G529.     CrossRef
  • Does Bilateral Deep Brain Stimulation of the Subthalamic Nucleus Modify Ano-Rectal Motility in Parkinson’s Disease? Results of a Randomized Cross-Over Study
    Guillaume Gourcerol, David Maltete, Nathalie Chastan, Marie Laure Welter, Anne Marie Leroi, Stéphane Derrey
    Neuromodulation: Technology at the Neural Interface.2019; 22(4): 478.     CrossRef
  • Probiotics for Parkinson’s Disease
    Gazerani
    International Journal of Molecular Sciences.2019; 20(17): 4121.     CrossRef
  • Colon dysregulation in methamphetamine self-administering HIV-1 transgenic rats
    Amanda L. Persons, Brinda D. Bradaric, Hemraj B. Dodiya, Michael Ohene-Nyako, Christopher B. Forsyth, Ali Keshavarzian, Maliha Shaikh, T. Celeste Napier, Shilpa J. Buch
    PLOS ONE.2018; 13(1): e0190078.     CrossRef
  • Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology
    Fredric P. Manfredsson, Kelvin C. Luk, Matthew J. Benskey, Aysegul Gezer, Joanna Garcia, Nathan C. Kuhn, Ivette M. Sandoval, Joseph R. Patterson, Alana O'Mara, Reid Yonkers, Jeffrey H. Kordower
    Neurobiology of Disease.2018; 112: 106.     CrossRef
  • Dysbiosis of gut microbiota and microbial metabolites in Parkinson’s Disease
    Meng-Fei Sun, Yan-Qin Shen
    Ageing Research Reviews.2018; 45: 53.     CrossRef
  • Parkinson’s Disease and Current Treatments for Its Gastrointestinal Neurogastromotility Effects
    Chethan Ramprasad, Jane Yellowlees Douglas, Baharak Moshiree
    Current Treatment Options in Gastroenterology.2018; 16(4): 489.     CrossRef
  • Transdermal rotigotine patch in Parkinson’s disease with a history of intestinal operation
    Takashi Ogawa, Genko Oyama, Nobutaka Hattori
    BMJ Case Reports.2018; : bcr-2017-223722.     CrossRef
  • α-Synuclein in the colon and premotor markers of Parkinson disease in neurologically normal subjects
    Joong-Seok Kim, In-Seok Park, Hyung-Eun Park, Su-Young Kim, Jung A Yun, Chan Kwon Jung, Hye-Young Sung, Jin-Kwon Lee, Won-Kyung Kang
    Neurological Sciences.2017; 38(1): 171.     CrossRef
  • The Threshold Theory for Parkinson's Disease
    Simone Engelender, Ole Isacson
    Trends in Neurosciences.2017; 40(1): 4.     CrossRef
  • Constipation in parkinson's disease: Subjective symptoms, objective markers, and new perspectives
    Karoline Knudsen, Klaus Krogh, Karen Østergaard, Per Borghammer
    Movement Disorders.2017; 32(1): 94.     CrossRef
  • Is Levodopa Pharmacokinetics in Patients with Parkinson’s Disease Depending on Gastric Emptying?
    Maria Nord, Anita Kullman, Ulf Hannestad, Nil Dizdar
    Advances in Parkinson's Disease.2017; 06(01): 1.     CrossRef
  • Validation of the Korean Version of the Scale for Outcomes in Parkinson’s Disease-Autonomic
    Ji-Young Kim, In-Uk Song, Seong-Beom Koh, Tae-Beom Ahn, Sang Jin Kim, Sang-Myung Cheon, Jin Whan Cho, Yun Joong Kim, Hyeo-Il Ma, Mee-Young Park, Jong Sam Baik, Phil Hyu Lee, Sun Ju Chung, Jong-Min Kim, Han-Joon Kim, Young-Hee Sung, Do Young Kwon, Jae-Hyeo
    Journal of Movement Disorders.2017; 10(1): 29.     CrossRef
  • Gastroesophageal reflux disease with proton pump inhibitor use is associated with an increased risk of osteoporosis: a nationwide population-based analysis
    C.-H. Chen, C.-L. Lin, C.-H. Kao
    Osteoporosis International.2016; 27(6): 2117.     CrossRef
  • Parkinson Disease-Mediated Gastrointestinal Disorders and Rational for Combinatorial Therapies
    Syed Ali, Ning Yin, Arkam Rehman, Verline Justilien
    Medical Sciences.2016; 4(1): 1.     CrossRef
  • Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models
    C. Pellegrini, R. Colucci, L. Antonioli, E. Barocelli, V. Ballabeni, N. Bernardini, C. Blandizzi, W. J. de Jonge, M. Fornai
    Neurogastroenterology & Motility.2016; 28(12): 1781.     CrossRef
  • Gut dysfunction in Parkinson's disease
    Adreesh Mukherjee, Atanu Biswas, Shyamal Kumar Das
    World Journal of Gastroenterology.2016; 22(25): 5742.     CrossRef
  • Inflammation is genetically implicated in Parkinson’s disease
    N. Dzamko, C.L Geczy, G.M Halliday
    Neuroscience.2015; 302: 89.     CrossRef
  • Alteration of enteric monoamines with monoamine receptors and colonic dysmotility in 6-OHDA-induced Parkinson’s disease rats
    Xiaoli Zhang, Yun Li, Chenzhe Liu, Ruifang Fan, Ping Wang, Lifei Zheng, Feng Hong, Xiaoyan Feng, Yue Zhang, Lisheng Li, Jinxia Zhu
    Translational Research.2015;[Epub]     CrossRef
  • The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson’s disease
    Jose L Barboza, Michael S Okun, Baharak Moshiree
    Expert Opinion on Pharmacotherapy.2015; 16(16): 2449.     CrossRef
  • Gastrointestinal Dysfunctions in Parkinson’s Disease
    Joong-Seok Kim, Hey Young Sung
    Journal of the Korean Neurological Association.2015; 33(4): 247.     CrossRef

JMD : Journal of Movement Disorders